Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Fish and Richardson
Accenture
McKesson
AstraZeneca
Novartis
Covington
Harvard Business School
Cerilliant

Generated: January 16, 2018

DrugPatentWatch Database Preview

PRINZIDE Drug Profile

« Back to Dashboard

When do Prinzide patents expire, and what generic alternatives are available?

Prinzide is a drug marketed by Merck and is included in one NDA.

The generic ingredient in PRINZIDE is hydrochlorothiazide; lisinopril. There are thirty-one drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

US Patents and Regulatory Information for PRINZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-003 Nov 18, 1993 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-001 Feb 16, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-002 Feb 16, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PRINZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-002 Feb 16, 1989 ➤ Subscribe ➤ Subscribe
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-003 Nov 18, 1993 ➤ Subscribe ➤ Subscribe
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-003 Nov 18, 1993 ➤ Subscribe ➤ Subscribe
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-002 Feb 16, 1989 ➤ Subscribe ➤ Subscribe
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-001 Feb 16, 1989 ➤ Subscribe ➤ Subscribe
Merck PRINZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 019778-001 Feb 16, 1989 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Medtronic
Healthtrust
Novartis
Julphar
Cipla
Accenture
Fuji
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot